News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
234,325 Results
Type
Article (9472)
Company Profile (17)
Press Release (224836)
Section
Business (62774)
Career Advice (925)
Deals (13367)
Drug Delivery (19)
Drug Development (29350)
Employer Resources (27)
FDA (7773)
Job Trends (4831)
News (118359)
Policy (15647)
Tag
Academia (726)
Alliances (17895)
Alzheimer's disease (490)
Approvals (7729)
Artificial intelligence (69)
Bankruptcy (95)
Best Places to Work (4305)
Breast cancer (89)
Cancer (654)
Cardiovascular disease (49)
Career advice (735)
CAR-T (40)
Cell therapy (134)
Clinical research (23805)
Collaboration (243)
Compensation (183)
COVID-19 (803)
Cystic fibrosis (39)
Data (649)
Diabetes (66)
Diagnostics (2531)
Drug discovery (37)
Earnings (28355)
Events (26581)
Executive appointments (142)
FDA (8225)
Funding (216)
Gene therapy (79)
GLP-1 (170)
Government (1322)
Healthcare (5620)
Infectious disease (838)
Inflammatory bowel disease (55)
Interviews (201)
IPO (7037)
Job creations (682)
Job search strategy (576)
Layoffs (104)
Legal (2090)
Lung cancer (104)
Lymphoma (41)
Manufacturing (69)
Medical device (5157)
Medtech (5158)
Mergers & acquisitions (6511)
Metabolic disorders (128)
Neuroscience (635)
NextGen: Class of 2025 (1754)
Non-profit (718)
Northern California (770)
Obesity (52)
Opinion (55)
Patents (81)
People (13951)
Phase I (6821)
Phase II (9538)
Phase III (9863)
Pipeline (338)
Postmarket research (532)
Preclinical (3054)
Press Release (44)
Radiopharmaceuticals (116)
Rare diseases (134)
Real estate (1211)
Regulatory (13050)
Research institute (607)
Resumes & cover letters (241)
Southern California (693)
Startups (970)
United States (6488)
Vaccines (152)
Date
Today (89)
Last 7 days (371)
Last 30 days (927)
Last 365 days (15224)
2025 (531)
2024 (15388)
2023 (17419)
2022 (23681)
2021 (23502)
2020 (20858)
2019 (15780)
2018 (11510)
2017 (12119)
2016 (10378)
2015 (12252)
2014 (8552)
2013 (7358)
2012 (8136)
2011 (8586)
2010 (7573)
Location
Africa (184)
Asia (15093)
Australia (2673)
California (1724)
Canada (1004)
China (183)
Colorado (81)
Connecticut (90)
Europe (32197)
Florida (271)
Georgia (82)
Illinois (131)
Indiana (73)
Japan (50)
Maryland (247)
Massachusetts (1148)
Michigan (78)
Minnesota (95)
New Jersey (536)
New York (550)
North Carolina (278)
Northern California (770)
Ohio (47)
Pennsylvania (390)
South America (343)
Southern California (693)
Texas (238)
Utah (61)
Washington State (160)
234,325 Results for "ion beam applications iba".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Sickle cell disease
Vertex, Beam Report SCD Cell and Gene Therapies Advances at ASH 2024
Vertex unveiled long-term durability data for Casgevy, while Beam presented Phase I/II findings for its investigational base editor BEAM-101, building up to a BLA by late 2026.
December 9, 2024
·
2 min read
·
Tristan Manalac
Gene editing
Patient Death Taints Otherwise Positive Data for Beam’s Sickle Cell Gene Therapy
BEAM-101 seems to be competitive with approved sickle cell treatments, William Blair analysts said in a note to investors, but a patient death underscores the need for less-toxic preconditioning treatments.
November 5, 2024
·
3 min read
·
Annalee Armstrong
Centre for Ion Beam Applications at NUS designated as IAEA’s first Collaborating Centre in Singapore
The Centre for Ion Beam Applications (CIBA), a multidisciplinary research centre at the National University of Singapore (NUS), has recently been designated as an International Atomic Energy Agency (IAEA) Collaborating Centre for Research and Development of Accelerator Science and Multidisciplinary Applications.
September 20, 2023
·
8 min read
Press Releases
IBA Reports Half Year 2024 Results
August 29, 2024
·
6 min read
Press Releases
IBA and Jules Bordet Institute to lead IHI project Accelerate.EU to create complete Astatine-211 value chain
October 3, 2024
·
4 min read
Press Releases
IBA secures deal with the University of Pennsylvania Health System for two Proteus®ONE proton therapy solutions
August 27, 2024
·
3 min read
Business
NorthStar Medical Radioisotopes and IBA Sign Agreement for Two Additional Rhodotron® Electron Beam Accelerators for Commercial Production of Radioisotopes
NorthStar Medical Radioisotopes, LLC and IBA announced a new agreement under which NorthStar will purchase two additional Rhodotron® TT300 HE electron beam accelerators, and the associated beamlines, from IBA for the production of molybdenum-99.
September 20, 2022
·
5 min read
BioMidwest
NorthStar Medical Radioisotopes and IBA Sign Contract for Rhodotron® Electron Beam Accelerator for Commercial Production of Therapeutic Radioisotope Actinium-225 (Ac-225)
NorthStar Medical Radioisotopes, LLC (‘NorthStar’), and IBA (Ion Beam Applications S.A., EURONEXT), today announced a new contract in which NorthStar will purchase a third Rhodotron® TT300 HE electron beam accelerator from IBA.
November 18, 2021
·
5 min read
Press Releases
SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-opioid Treatments for Pain
December 18, 2024
·
4 min read
Press Releases
Ionis Announces Pivotal Phase 3 Trial Design for ION582 in Angelman Syndrome
November 6, 2024
·
6 min read
1 of 23,433
Next
